top of page
Browse by category
Search
Liraglutide after RYGB results in significant weight loss and resolution of obesity-related conditions
Adjunctive use of liraglutide at a dose of 3mg/day with conversional Roux-en-Y Gastric Bypass (cRYGB) results in significant weight loss,...
Discovery of Neuropeptide Y could lead to simpler and cheaper drugs to control obesity and weight gain
An international team of researchers has discovered a new component of the peripheral nervous system that acts by increasing energy...
Study examines California's legislative efforts on obesity and finds critical insights into policy trends and success rates over two decades
A recent multi-campus study, co-led by public health researchers from University of California (UC) Irvine and UC Merced, is the first of...
Allurion launches AllurionMeds first AI-native compounded GLP-1 program
Allurion Technologies has launched AllurionMeds, a unique offering to patients that combines affordable and accessible weight loss...
COMBINE trial: Glucose clamp technique as part of a new type 2 diabetes research trial
Researchers at Leicester Diabetes Centre (LDC) have successfully started using the glucose clamp technique as part of a new type 2...
Laekna and Eli Lilly to develop ActRIIA antibody for muscle-preserving weight loss in obesity
Laekna Therapeutics has entered a clinical collaboration with Eli Lilly to accelerate the development of LAE102, a novel Activin Receptor...
Browse by tag
bottom of page